Clinical Trial Update: Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of enzastaurin in breast cancer patients who previously received anthracycline and taxane chemotherapy; the trial status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enzastaurin (enzastaurin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED